These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 30197512)
1. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study. Buhl R; Criée CP; Kardos P; Vogelmeier CF; Kostikas K; Lossi NS; Worth H Int J Chron Obstruct Pulmon Dis; 2018; 13():2557-2568. PubMed ID: 30197512 [TBL] [Abstract][Full Text] [Related]
2. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study. Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047 [TBL] [Abstract][Full Text] [Related]
3. Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care. Landis SH; Wurst K; Le HV; Bonar K; Punekar YS COPD; 2017 Feb; 14(1):80-85. PubMed ID: 27819513 [TBL] [Abstract][Full Text] [Related]
4. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study. Vogelmeier CF; Worth H; Buhl R; Criée CP; Gückel E; Kardos P Respir Res; 2022 May; 23(1):109. PubMed ID: 35501806 [TBL] [Abstract][Full Text] [Related]
5. The reasons for triple therapy in stable COPD patients in Japanese clinical practice. Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T; Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629 [TBL] [Abstract][Full Text] [Related]
6. Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis. Mammen MJ; Lloyd DR; Kumar S; Ahmed AS; Pai V; Kunadharaju R; Gupta S; Nici L; Aaron SD; Alexander PE Ann Am Thorac Soc; 2020 Oct; 17(10):1308-1318. PubMed ID: 32692253 [No Abstract] [Full Text] [Related]
7. Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study. Dalon F; Roche N; Belhassen M; Nolin M; Pegliasco H; Deslée G; Housset B; Devillier P; Van Ganse E Int J Chron Obstruct Pulmon Dis; 2019; 14():1839-1854. PubMed ID: 31692478 [TBL] [Abstract][Full Text] [Related]
8. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy. Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905 [TBL] [Abstract][Full Text] [Related]
9. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Papi A; Vestbo J; Fabbri L; Corradi M; Prunier H; Cohuet G; Guasconi A; Montagna I; Vezzoli S; Petruzzelli S; Scuri M; Roche N; Singh D Lancet; 2018 Mar; 391(10125):1076-1084. PubMed ID: 29429593 [TBL] [Abstract][Full Text] [Related]
10. Role of Long-Acting Muscarinic Antagonist/Long-Acting β Petite SE Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560 [TBL] [Abstract][Full Text] [Related]
11. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm. Wilkie M; Finch S; Schembri S COPD; 2015; 12(5):582-90. PubMed ID: 25774769 [TBL] [Abstract][Full Text] [Related]
12. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK. Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512 [TBL] [Abstract][Full Text] [Related]
13. What is the role of triple inhaled therapy in COPD? Petite SE JAAPA; 2019 Oct; 32(10):44-45. PubMed ID: 31567741 [TBL] [Abstract][Full Text] [Related]
14. Triple Therapy in COPD: What We Know and What We Don't. Calverley PMA; Magnussen H; Miravitlles M; Wedzicha JA COPD; 2017 Dec; 14(6):648-662. PubMed ID: 29120273 [TBL] [Abstract][Full Text] [Related]
15. Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study. Jiang L; Kendzerska T; Aaron SD; Stukel TA; Stanbrook MB; Tan W; Pequeno P; Gershon AS COPD; 2022; 19(1):315-323. PubMed ID: 35946353 [TBL] [Abstract][Full Text] [Related]
16. [The stepwise approach of COPD therapy]. Watz H; Kirsten A; Greulich T Dtsch Med Wochenschr; 2019 Jan; 144(1):15-20. PubMed ID: 30602182 [TBL] [Abstract][Full Text] [Related]
17. Symptomatic burden of COPD for patients receiving dual or triple therapy. Chen S; Small M; Lindner L; Xu X Int J Chron Obstruct Pulmon Dis; 2018; 13():1365-1376. PubMed ID: 29731624 [TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Long-Acting Beta Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405 [TBL] [Abstract][Full Text] [Related]
19. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand. Xu X; Milea D; Navarro Rojas AA; Braganza A; Holbrook T; Marett B; Young R; Scott RJ; Gribben B Int J Chron Obstruct Pulmon Dis; 2021; 16():1835-1850. PubMed ID: 34177262 [TBL] [Abstract][Full Text] [Related]
20. Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy. Bengtson LGS; DePietro M; McPheeters J; Fox KM Ther Adv Respir Dis; 2018; 12():1753466618772750. PubMed ID: 29737943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]